You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
An analysis of six "Implementing Genomics in Practice" (IGNITE) consortium network projects pointed to three main challenges in implementing genomic medicine.
The arrangement will allow Illumina to market and promote Kailos' research solutions for pharmacogenetic target enrichment.
The number of institutions offering clinical exome or genome tests to healthy individuals keeps increasing, but the practice remains controversial among medical experts.
Genelex is hoping that a recently published randomized-controlled trial will help it get on better footing with Medicare.
Geneticure has raised around $1.1 million to fund the study, which may very well be the largest prospective RCT for personalization of high blood pressure treatment.
The Canadian company recently published results of a study demonstrating the utility of its pharmacogenomic testing and decision support platform.
The Pharmacogenomics Clinical Annotation Tool interprets variants from sequencing or genotyping tests and generates a report to inform prescribing decisions.
A new PGen study reports that nearly 6 percent of consumers made changes to their prescription medication based on pharmacogenomic testing.
The revisions, which are subject to approval by the ACMG board of directors, will likely involve the addition of five genes and the removal of one gene from the list.
NHGRI researchers showed that they were able to extract more useful pharmacogenetic information from exome data than from current chip data.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.